We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Gastroenterology

Journal Scan / Research · December 17, 2019

Baseline Cirrhosis Increases Risk of Hepatocellular Carcinoma Long After HCV Eradication



Additional Info

Disclosure statements are available on the authors' profiles:

Increased Risk for Hepatocellular Carcinoma Persists up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores
Gastroenterology 2019 Nov 01;157(5)1264-1278.e4, GN Ioannou, LA Beste, PK Green, AG Singal, EB Tapper, AK Waljee, RK Sterling, JJ Feld, DE Kaplan, TH Taddei, K Berry

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading